UK Vein Clinic Group Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—5

Registered number: 12651713

		2024		2023
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		154,728		143,212
Investments	5		29,857		29,857

			184,585		173,069
CURRENT ASSETS
Stocks	6	88,403		-
Debtors	7	3,314,039		1,503,490
Cash at bank and in hand		405,927		1,183,851

		3,808,369		2,687,341
Creditors: Amounts Falling Due Within One Year	8	(62,950 )		(206,387 )

NET CURRENT ASSETS (LIABILITIES)			3,745,419		2,480,954

TOTAL ASSETS LESS CURRENT LIABILITIES			3,930,004		2,654,023

Creditors: Amounts Falling Due After More Than One Year	9		(3,781,717 )		(2,546,245 )

PROVISIONS FOR LIABILITIES
Deferred Taxation			(38,682 )		(73,303 )

NET ASSETS			109,605		34,475

CAPITAL AND RESERVES
Called up share capital	10		1,990		1,990
Share premium account			303		303
Capital redemption reserve			(24,990 )		(24,990 )
Profit and Loss Account			132,302		57,172

SHAREHOLDERS' FUNDS			109,605		34,475

Page 1

Page 2

UK Vein Clinic Group Limited

Balance Sheet (continued)

As At 31 December 2024

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr J E Powell

Director

29 September 2025

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

UK Vein Clinic Group Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12651713 . The registered office is Lower Ground Floor, 150 Harley Street, London, W1G 7LQ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery	20 % Straight Line
Fixtures & Fittings	20 % Straight Line
Computer Equipment	20 % Straight Line

2.4. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

2.5. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

Page 3

Page 4

UK Vein Clinic Group Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

3. Average Number of Employees

Average number of employees, including directors, during the year was: 36 (2023: 45)

4. Tangible Assets

	Plant & Machinery	Fixtures & Fittings	Computer Equipment	Total
	£	£	£	£
Cost
As at 1 January 2024	728	3,784	234,963	239,475
Additions	429	5,688	80,050	86,167

As at 31 December 2024	1,157	9,472	315,013	325,642

Depreciation
As at 1 January 2024	134	60	96,069	96,263
Provided during the period	146	936	73,569	74,651

As at 31 December 2024	280	996	169,638	170,914

Net Book Value
As at 31 December 2024	877	8,476	145,375	154,728

As at 1 January 2024	594	3,724	138,894	143,212

5. Investments

	Other
	£
Cost
As at 1 January 2024	29,857

As at 31 December 2024	29,857

Provision
As at 1 January 2024	-

As at 31 December 2024	-

Net Book Value
As at 31 December 2024	29,857

As at 1 January 2024	29,857

6. Stocks

	2024	2023
	£	£
Stock	88,403	-

Page 4

Page 5

UK Vein Clinic Group Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

7. Debtors

	2024	2023
	£	£
Due within one year
Prepayments and accrued income	132,019	175,300
Other debtors	6,200	19,939
Directors' loan accounts	-	97,806

	138,219	293,045
Due after more than one year
Amounts owed by group undertakings	3,175,820	1,210,445

	3,314,039	1,503,490

8. Creditors: Amounts Falling Due Within One Year

	2024	2023
	£	£
Trade creditors	(294 )	52,733
Other taxes and social security	47,993	44,209
Other creditors	9,451	14,100
Accruals and deferred income	5,800	95,345

	62,950	206,387

9. Creditors: Amounts Falling Due After More Than One Year

	2024	2023
	£	£
Bank loans	1,500,000	1,500,000
Amounts owed to group undertakings	2,281,717	1,046,245

	3,781,717	2,546,245

10. Share Capital

	2024	2023
	£	£
Allotted, Called up and fully paid	1,990	1,990

11. Directors Advances, Credits and Guarantees

Included within Debtors are the following loans to directors:£97,806.06.

The above loan is unsecured, interest free and repayable by 1st of October 2024.

12. Related Party Transactions

Dr Newmans Clinic Limited - Intercompany balance: Dr £2,566,158, (2023 Dr £1,039,674)

UK Vein Clinic Ltd - Intercompany balance: Cr £2,281,717, (2023 Cr £1,046,245)

Uk Vein Clinic (Thames Valley) Ltd - Intercompany balance: Dr £424,578, (2023 Dr £147,686)

Uk Vein Clinic Cambridge Ltd - Intercompany balance: Dr £96,935, (2023 Dr £3,558)

Uik Vein Clinic Surrey Ltd - Intercompany balance: Dr £88,149 (2023 Dr £88,149)

13. Ultimate Controlling Party

There is no company's controlling party, due to shareholders holding equal amount of shares.

Page 5